EDIUNET Free equity investment tool of Japanese companies

Companies Cart
@
Financial Indicator Details
Annual
First quarter
Second quarter
Third quarter
Sponsored Link
Related Company
@ 中外製薬 +
@ 持田製薬 +
@ Takeda Pharmaceutical +
@ ダイセル +
@ 長谷川香料 +
@ Otsuka Holdings +
@ The Nippon Synthetic Chemical Industry +
@ 大正製薬ホールディングス +
@ ONO PHARMACEUTICAL +
@ Nihon Parkrizing +
@ アステラス製薬 +
@ Aica Kogyo +
@ Nissan Chemical Industries +
@ エスケー化研 +
@ Kuraray +
EDIUNET Related Ranking
EDIUNET
EDIUNET Credit Rating
EDIUNET Industry Avg
EDIUNET Prefectures
Yuho! Industry
EDIUNET Rating News
Prev « 2024-04 » Next
Mon Tue Wed Thu Fri Sat Sun
1
-		 2
-		 3
-		 4
-		 5
-		 6
-		 7
-
8
-		 9
-		 10
-		 11
-		 12
-		 13
-		 14
-
15
-		 16
-		 17
-		 18
-		 19
-		 20
-		 21
-
22
-		 23
-		 24
-		 25
-		 26
-		 27
-		 28
-
29
-		 30
-
[Update list]
10/30 Real Estate (DAIBIRU:BBB→A e..
 RSS
 Company RSS
 Daily RSS
Sponsored Link
Recently Download Chart
日本アビオニクス
graph
日本アビオニクス
graph
日本アビオニクス
graph
Renesas Electronics
graph
日本セラミック
graph

Financial Indicator Details: アステラス製薬+Mitsubishi Tanabe Pharma (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 @Outline @Statement @Rating @Indicator @Download

Sponsored Link

*Free Download Financial Indicator data

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability アステラス製薬
(2013-03-31)
Mitsubishi Tanabe Pharma
(2013-03-31)
Net profit margin8.23%9.99%
C/F margin14.33%14.45%
ROA5.73%4.83%
ROE7.80%5.56%
Growth アステラス製薬
(2013-03-31)
Mitsubishi Tanabe Pharma
(2013-03-31)
Capital adequacy73.46%86.86%
Liquidity ratio263.82%553.52%
C/F ratio current liabilities217.50%142.13%
Quick ratio165.81%174.35%
Stability アステラス製薬
(2013-03-31)
Mitsubishi Tanabe Pharma
(2013-03-31)
Equity growth4.31%4.35%
Sales growth3.73%2.95%
Net profit growth5.90%7.37%
Operating C/F growth-16.51%62.66%
Turnover アステラス製薬
(2013-03-31)
Mitsubishi Tanabe Pharma
(2013-03-31)
Inventory turnover46.52day80.79day
Receivables turnover103.83day113.08day
Payable turnover37.32day33.15day
Working capita turnover113.03day160.72day
Market Value growth48.82%24.46%
Dividend Yield2.53%2.76%
PER28.58%19.36%
PBR2.22%1.07%
PCFR16.42%13.38%
PSR2.35%1.93%
View the financial indicators, more.

Financial Indicator Details: アステラス製薬+Mitsubishi Tanabe Pharma

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator アステラス製薬
(2013-03-31)
Mitsubishi Tanabe Pharma
(2013-03-31)
Profitability
Net profit margin8.07%9.58%
C/F margin17.81%9.14%
ROA5.58%4.75%
ROE7.68%5.40%
Recurring margin13.93%16.88%
EBIT margin12.99%15.28%
EBITDA margin18.54%18.34%
NOPAT margin7.79%9.17%
Sales SG rates32.86%37.40%
Sales SG&A rates53.56%45.64%
Sales R&D expenses rates-17.25%
Sales depreciation rates5.54%3.06%
Capital expenditures net sales ratio-4.91%-2.33%
Indicator アステラス製薬
(2013-03-31)
Mitsubishi Tanabe Pharma
(2013-03-31)
Growth
Growth rate of cash47.65%-43.57%
Equity growth-0.29%3.66%
Total assets growth4.90%0.14%
Sales growth1.61%-0.58%
Net profit growth15.63%3.35%
Operating C/F growth71.57%-36.94%
Recurring profit growth17.42%-10.33%
EBIT growth22.93%-0.53%
EBITDA growth14.48%-0.39%
NOPAT growth22.93%-0.53%
Operating expenses growth--
Indicator アステラス製薬
(2013-03-31)
Mitsubishi Tanabe Pharma
(2013-03-31)
Stability
Capital adequacy72.69%87.99%
Liquidity ratio248.61%603.08%
C/F ratio current liabilities181.94%186.81%
Quick ratio151.40%205.03%
Fixed ratio19.56%14.40%
D/E ratio-0.30%
Loan to Value Ratio-0.26%
Business investment C/F ratio-27.61%-25.51%
Liabilities with interest growth--24.93%
Indicator アステラス製薬
(2013-03-31)
Mitsubishi Tanabe Pharma
(2013-03-31)
Turnover
Cash turnover79.44day13.86day
Receivables turnover99.66day114.03day
Inventory turnover42.10day77.26day
Fixed assets turnover74.98day93.16day
Total asset turnover527.37day735.03day
Payable turnover40.81day25.88day
Capital turnover38.78day44.82day
Equity turnover383.35day646.78day
Working capita turnover100.94day165.41day
Indicator アステラス製薬
(2013-03-31)
Mitsubishi Tanabe Pharma
(2013-03-31)
Balance sheet
Cash etc.¥ 312 B¥ 22 B
Accounts receivable-trade¥ 228 B¥ 126 B
Other Current Assets¥ 676 B¥ 321 B
Current Assets¥ 988 B¥ 344 B
Tangible Assets¥ 184 B¥ 117 B
Intangible Assets¥ 62 B¥ 129 B
Investment etc.¥ 128 B¥ 205 B
Total Assets¥ 1.3 T¥ 796 B
Current Liabilities¥ 277 B¥ 77 B
Fixed Liabilities¥ 33 B¥ 42 B
Liabilities with interest-¥ 2 B
Net Assets¥ 1.0 T¥ 676 B
Capital stock¥ 103 B¥ 50 B
Capital surplus etc.¥ 950 B¥ 626 B
Liabilities and net assets¥ 1.3 T¥ 796 B
Indicator アステラス製薬
(2013-03-31)
Mitsubishi Tanabe Pharma
(2013-03-31)
Income statement
Sales¥ 974 B¥ 404 B
Cost of Sales¥ 289 B¥ 147 B
Gross profit¥ 685 B¥ 256 B
Other income¥ 8 B¥ 3 B
SG&A¥ 499 B¥ 195 B
Other expenses¥ 70 B¥ 36 B
Net income¥ 122 B¥ 30 B
Operating income¥ 186 B¥ 61 B
Ordinary Income¥ 190 B¥ 61 B
EBITDA¥ 222 B¥ 62 B
Income before income taxes¥ 186 B¥ 50 B
Depreciation¥ 38 B¥ 13 B
R&D expenses¥ 195 B¥ 83 B
Income taxes¥ 62 B¥ 22 B
Indicator アステラス製薬
(2013-03-31)
Mitsubishi Tanabe Pharma
(2013-03-31)
Cash flow statement
Operating CF¥ 150 B¥ 23 B
Investment CF¥ -31 B¥ -61 B
Financial CF¥ -85 B¥ -17 B
Foreign Exchange Effects¥ -10 B¥ 274 M
Net Change in Cash¥ 22 B¥ -54 B
Free CF¥ 118 B¥ -37 B
Capital expenditures¥ -39 B¥ -8 B
Cash dividends paid¥ -58 B¥ -15 B
Repayment loans-¥ -923 M
Indicator アステラス製薬
(2013-03-31)
Mitsubishi Tanabe Pharma
(2013-03-31)
Shareowners' equity
Issuance of new shares--
Dividends from surplus¥ -56 B¥ -15 B
Net income¥ 122 B¥ 30 B
Purchase of treasury stock¥ -26 B¥ -3 M
Other Change in Stockholders Equity¥ -1 M¥ 156 M
Other Change in Net Assets¥ -15 B¥ -4 B
Net Change in Net Assets¥ 23 B¥ 10 B

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: アステラス製薬  Mitsubishi Tanabe Pharma 

Statement Type
Annual : アステラス製薬+Mitsubishi Tanabe Pharma
First quarter : アステラス製薬+Mitsubishi Tanabe Pharma
Second quarter : アステラス製薬+Mitsubishi Tanabe Pharma
Third quarter : アステラス製薬+Mitsubishi Tanabe Pharma
Analysis Menu
@Outline : アステラス製薬+Mitsubishi Tanabe Pharma
@Statement : アステラス製薬+Mitsubishi Tanabe Pharma
@Rating : アステラス製薬+Mitsubishi Tanabe Pharma
@Indicator : アステラス製薬+Mitsubishi Tanabe Pharma
@Download : アステラス製薬+Mitsubishi Tanabe Pharma
Industry Comparison Ranking
Chemicals - EDIUNET Industry Rankings
Chemicals - EDIUNET Credit Rating
Chemicals - EDIUNET Industry Avg
Comparison with a neighboring company
Tokyo - EDIUNET Prefectures
Tokyo中央区 - EDIUNET Prefectures
Osaka - EDIUNET Prefectures
Osaka大阪市 - EDIUNET Prefectures

Related company's newest statement

Date Company Credit Rating Date
1/23 Milbon AA→AAA 2013-12-20
1/17 Kawaguchi Chemical Indu.. BBB→BB 2013-11-30
1/17 SANKEI CHEMICAL A 2013-11-30
1/15 HOKKO CHEMICAL INDUSTRY BB→B 2013-11-30
1/15 Daito Pharmaceutical Co . AA 2013-11-30 (Q2)
1/15 KAWAKAMI PAINT MFG. B→BB 2013-11-30
1/15 旭化学工業 AA 2013-11-30 (Q1)
1/10 OSAKA ORGANIC CHEMICAL .. BB→BBB 2013-11-30
1/10 HISAMITSU PHARMACEUTICAL A 2013-11-30 (Q3)
1/10 AMS Life Science BBB→BB 2013-11-30 (Q1)
EDIUNET Investment News (Chemicals)
1/23 Chemicals (Milbon:AA→AAA)
1/17 Chemicals (Kawaguchi Chemica..
1/15 Chemicals (HOKKO CHEMICAL IN..
1/10 Chemicals (OSAKA ORGANIC CHE..
1/9 Chemicals (SANKO GOSEI:A)
12/27 Chemicals (Niitaka:A)
12/18 Chemicals (KUMIAI CHEMICAL I..
12/12 Chemicals (IHARA CHEMICAL IN..
12/11 Chemicals (Konoshima Chemica..
12/10 Chemicals (NATOCO:AA)

Ticker Market Industry Month report Rating
@ アステラス製薬 4503 TSE 1st Chemicals 3 Annual A
@ Mitsubishi Tanabe Pharma 4508 TSE 1st Chemicals 3 Annual A

Related Company

@ ダイセル (Sales ¥ 358 B) +
@ ONO PHARMACEUTICAL (Sales ¥ 145 B) +
@ 長谷川香料 (Sales ¥ 45 B) +
@ 持田製薬 (Sales ¥ 89 B) +
@ Sekisui Chemical (Sales ¥ 1.0 T) +
@ NIHON NOHYAKU (Sales ¥ 47 B) +
@ 関西ペイント (Sales ¥ 294 B) +
@ TSUMURA & CO. (Sales ¥ 105 B) +
@ The Nippon Synthetic Chemical Industry (Sales ¥ 91 B) +
@ Mitsubishi Tanabe Pharma (Sales ¥ 419 B) +
@ Kuraray (Sales ¥ 369 B) +
@ ROHTO PHARMACEUTICAL (Sales ¥ 129 B) +
@ Shin-Etsu Chemical (Sales ¥ 1.0 T) +

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .

▲ Go to the top ▲

  1. Guide
  2. Mobile
  3. Tablet
  4. Japanese
`EDIUNET` Copyright©2006-2024 `ＭＡバンク` (1.290 sec.)